From my understanding PSMA are very accurate in determining PCa spread, but it also it is also would be diagnostic in discovering PCa in the Prostate.
If other screening tools such as PSA, DRE, and perhaps MRI indicate suspicions for PCa, instead of using biopsy, why not employ PSMA to determine if a biopsy is even necessary?
If the PSMA indicate a PCa in the prostate, then proceed with a directed biopsy to determine the Gleason grade to determine if Active Surveillance is an option?
Written by
Yearofthecow
To view profiles and participate in discussions please or .
most of the procedures we receive - for this disease and other medical issues are expensive in this country and as recent events point out, the people who make the decisions about which procedure and what will be paid ... have a great deal of power. Are they using it with compassion and ethically? Maybe - maybe not
My point wasn’t that a biopsy wasn’t necessary, but only if the PSMA was positive would it be necessary, because you need to determine the Gleason grade.
The Gleason Score was invented as an indirect indicator of the PCa progression and in particular it's probabilistic correlation to a metastasized disease. Now, that there is a means of a direct look into the latter, it is redundant. Rhetorical question: Which of the two will provide a more concrete indication for SVI? As to the internals of the prostate a mpMRI is way more specific than any biopsy. Hence, the combo of mpMRI and PSMA PET gives a more solid indication of the disease's progression. But, some will loose a part of their income, if you prefer the bare truth to the marketing hype.
So .....how does calculus have anything to do with this and the value of doubling time when PSA < 0,1??????? Evidently you don't know of any study conclusively proving the value of such doubling time. Just accept your assertion?
That wasn’t my question or point. I was speculating that perhaps the biopsy can be avoided is the PSMA scan was negative. If it is positive then a biopsy would absolutely need to be followed up to determine the Gleason grade.
No, you got that wrong. PSMA PET scans have only about 40% sensitivity for finding metastatic spread. It is not at all diagnostic for finding PCa in the prostate.
No it doesn’t because it has never been approved for that. What I read from it is that it is very accurate if PSA values are >1, and I was simply suggesting why couldn’t it be used as a diagnostic, and if it is positive in the prostate bed then proceed with a biopsy to determine the grade, otherwise just continue on AS.
It was just a speculation, no tasting this is a protocol that should be followed.
It has never been used for that because it is not diagnostic. PSMA is a protein that appears on prostate cancer cells as it progresses, so it is ill-suited as an early screening tool.
With a rising PSA in 2020 I had a PSMA PET/CT performed that showed up NOTHING. Dr. was still concerned so ordered a 3TmpMRI for remaining half of prostate check. Indicated nothing other than some enlargement then next PSA dramatically lowered.
Had rapid rise in to 12ng/mL PSA late 2023. The PSMA PET/CT showed 3 spots in left remaining prostate lighting up with the rest was clear.
Had the most complete rendition of a prostate biopsy available with the prostate still within, the Saturation Transperineal 3Dimension Prostate MAPPING Biopsy that yielded 47 cores for sampling with 3 cores positive at 3+3. Currently on Watchful Waiting. Scans can be totally WRONG!!!
Thanks. I realize that scans can be wrong or incomplete without complementary imaging or biopsy. In fact, I've been trying to make my own docs aware of that since they all seem to regard the PSMA as next to infallible among scans (leaving biopsy aside).
Still, TA's specific comment on this post left me confused. Perhaps he was addressing the issue of initial confirmation of PCa, but that wasn't clear to me.
Very interesting. Thanks for the example that nothing is perfect, even biopsies, though a saturated Tp biopsy like you had narrowed that window significantly.
The first TP-3D-PMB I had for the whole prostate yielded 100+ core samples for inspection. It provided clear borders for the GL 10 tumor in the right half so only that half required Cryoablation using enough probes to ablate the entire prostate.
PSMA PET scans have low sensitivity for finding metastases but high specificity. Because PSMA doesn't appear on the surface of prostate cancer until it has progressed, it is particularly ill-suited for early prostate cancer detection. It also has a high false positive rate in and around the prostate due to kidney excretion.
Thanks for the clarification. My first and only PSMA in July showed no abnormal uptake outside the prostate (contradicting earlier Axumin scans) but showed 24.7 SUV max in prostate, much higher than Axumins had shown (around 4.5-4.8,). I don't know if there is a normal uptake for prostate or if SUV max levels for PSMA are on the same scale as Axumin.
Yes, I suspected that. In January, six months earlier, my latest Axumin showed about 4.7, roughly the same as the previous 3 going back to 1/2020. Am I correct that the PSMA uptake in prostate cannot be compared directly to Axumin uptake in prostate?
Even normal prostate cells express PSMA-protein, that's why PSMA-scan can't tell if the cell is cancerous or not. However if PSMA-scan shows something outside of prostate then it's definitely a metastasis because, normally, prostate cells are not living outside of prostate.
PSMA was how I found I had a bone mat in my hip socket in 2019. After three years of Lupron and abiraterone I had another PSMA…F18 last January. It showed that the bone met was gone and I am now considered in remission..
I had Biopsy's but since they so inaccurate, both times the Doc didn't think we would see anything and they were right both times. If a PSMA Test shows something then you know its bad and spreading!
Doc ordered both tests. 1st time I didn't have insurance and negotiated the price and down to $8,000, that 4 years ago. Second time USA MEDICARE picked up the tab.
murk if the PSMA show it is confined to the prostate bed that would not necessarily mean it is spreading unless it showed outside the prostate I believe.
A PSMA Test isn't good enough, accurate, nor can it guarantee that cancer has not metastasized (spread). It is only good for confirming that it has. This is why some Doc's, insurances or Countries with National Healthcare do not recommend, offer or pay for these tests. All just IMO
BEFORE diagnosis only an examination of cells with microscope can determine cancer diagnosis. Unless advanced with widespread mets in expected locations and standard symptoms. In which case go straight to treatment.
After diagnosis scans MAY indicate likely cancer in nodes/organs. This is not infallible. Occasionally a biopsy is necessary in such instances. Other times treatment follows on the assumption of metastasis.
Nonetheless screening, in other words testing of a broad range of individuals without diagnoses, is not recommended. Biopsy of a wide number of me age 65+ might find cancer but will never be adopted due to cost and risk. Scans, same thing.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.